Frazier Life Sciences Management, L.p.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
47
Total Value
2187908599
Accession Number
0001892134-25-000005
Form Type
13F-HR
CIK
0001892134
Manager Name
Frazier Life Sciences Management, L.p.
Data Enrichment
96% identified
45 identified2 unidentified

Holdings

47 positions
Manager:
SEC
Search and click to pin securities to the top
Page 2 of 3
Ascendis Pharma A/S
ASND|04351P101
Shares:
133333(+0.0%)
Value:
$20.8B(+13.2%)
Vaxcyte, Inc.
PCVX|92243G108
Shares:
539405(+0.0%)
Value:
$20.4B(-53.9%)
Alkermes plc.
ALKS|G01767105
Shares:
601129(+0.0%)
Value:
$19.8B(+14.8%)
PALVELLA THERAPEUTICS, INC.
PVLA|697947109
Shares:
690012(+5.5%)
Value:
$19.3B(+146.1%)
CG Oncology, Inc.
CGON|156944100
Shares:
770000(+0.0%)
Value:
$18.9B(-14.6%)
Mereo BioPharma Group plc
MREO|589492107
Shares:
7819863(+53.4%)
Value:
$17.6B(-1.4%)
Merus N.V.
MRUS|N5749R100
Shares:
373100(+0.0%)
Value:
$15.7B(+0.1%)
Avidity Biosciences, Inc.
RNA|05370A108
Shares:
525000
Value:
$15.5B
HilleVax, Inc.
HLVX|43157M102
Shares:
10617062(+0.0%)
Value:
$15.4B(-29.9%)
Dyne Therapeutics, Inc.
DYN|26818M108
Shares:
1443341
Value:
$15.1B
Zai Lab Ltd
ZLAB|98887Q104
Shares:
350000
Value:
$12.6B
Immunocore Holdings plc
IMCR|45258D105
Shares:
301170(+176.9%)
Value:
$8.9B(+178.5%)
Oric Pharmaceuticals, Inc.
ORIC|68622P109
Shares:
1410193(-63.7%)
Value:
$7.9B(-74.9%)
ACADIA PHARMACEUTICALS INC
ACAD|004225108
Shares:
470338(+0.0%)
Value:
$7.8B(-9.5%)
Design Therapeutics, Inc.
DSGN|25056L103
Shares:
1953547(+0.0%)
Value:
$7.5B(-37.4%)
ROCKET PHARMACEUTICALS, INC.
RCKT|77313F106
Shares:
1079025(-27.0%)
Value:
$7.2B(-61.3%)
Autolus Therapeutics plc
AUTL|05280R100
Shares:
4623324(+0.0%)
Value:
$7.2B(-34.0%)
Oruka Therapeutics, Inc.
ORKA|687604108
Shares:
583327(+0.0%)
Value:
$6.0B(-47.1%)
Allogene Therapeutics, Inc.
ALLO|019770106
Shares:
3868750(+34.9%)
Value:
$5.6B(-7.5%)
Immatics N.V.
IMTX|N44445109
Shares:
1247911(-41.9%)
Value:
$5.6B(-63.1%)